Beckman Coulter Life Sciences and Invitae Enter into Application Development Agreement for the Biomek NGeniuS System
INDIANAPOLIS – (September 27, 2021) – Beckman Coulter Life Sciences today announced it has entered into an application development agreement with Invitae (NYSE: NVTA), a leading medical genetics company, to enable the development of new applications on its newest NGS automation platform, the Biomek NGeniuS Next Generation Library Prep System.
The Biomek NGeniuS Liquid Handling System* is a purpose-built liquid handler for NGS library preparation. It provides an easy-to-use solution that reduces manual transfers and hands-on time for the traditionally labor-intensive process of library construction.
“Partnerships between Beckman Coulter Life Sciences and reagent manufacturers will accelerate the automation of NGS library prep kits, expanding the menu of the Biomek NGenuiS liquid handler while harnessing our automation expertise and the library preparation portfolio of partners like Invitae,” said Jason Lanie, Vice President and General Manager of the Biotechnology Business Unit at Beckman Coulter Life Sciences.
In this partnership Invitae will develop applications specifically designed for the Biomek NGeniuS liquid handler, which will be available to Biomek NGeniuS instrument users via a first-of-its-kind electronic application library. The Biomek NGeniuS System itself is scheduled to launch in early 2022.
“Together with Beckman Coulter Life Sciences, we’ll increase automation and reduce laboratory preparation time required of researchers, including current and future labs using Invitae’s kit-based products, who are advancing the field of precision oncology,” said Vishal Sikri, president of Oncology at Invitae.
Invitae Corporation (NYSE: NVTA) is a leading medical genetics company, whose mission is to bring comprehensive genetic information into mainstream medicine to improve healthcare for billions of people. Invitae's goal is to aggregate the world's genetic tests into a single service with higher quality, faster turnaround time, and lower prices. For more information, visit the company's website at invitae.com.
Invitae Safe Harbor Statement
This press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, including statements relating to Invitae’s partnership with Beckman Coulter and the expected results therefrom. Forward-looking statements are subject to risks and uncertainties that could cause actual results to differ materially and reported results should not be considered as an indication of future performance. These risks and uncertainties include, but are not limited to: Invitae’s history of losses; Invitae’s ability to compete; Invitae’s failure to manage growth effectively; Invitae’s need to scale its infrastructure in advance of demand for its tests and to increase demand for its tests; Invitae’s ability to use rapidly changing genetic data to interpret test results accurately and consistently; laws and regulations applicable to Invitae’s business; and the other risks set forth in Invitae’s filings with the Securities and Exchange Commission, including the risks set forth in Invitae’s Quarterly Report on Form 10-Q for the quarter ended March 31, 2021. These forward-looking statements speak only as of the date hereof, and Invitae disclaims any obligation to update these forward-looking statements.
About Beckman Coulter Life Sciences
Life sciences. Research. Precision manufacturing. If your life’s calling is in any of these or related fields, you need to know Beckman Coulter Life Sciences. Our mission is to empower those seeking answers to life’s important scientific and healthcare questions. Since 1935, the Beckman name has been synonymous with technologies that simplify and automate complex biomedical testing. Decades later, our global organization also came to embody the scientific legacy of the Coulter name. Today, Beckman Coulter Life Sciences is a trusted, worldwide resource for tools to help optimize research and manufacturing efficiency. Centrifuges. Particle counters/analyzers. Automated liquid handlers. Flow cytometers. Genomic reagents. All these products—and many more—continue to make a difference in people’s lives by improving the productivity of dedicated scientists, quality control experts and others. Wherever people need answers, from prestigious universities and major pharmaceutical companies, to small biotech startups, food/beverage and electronics manufacturing facilities, you can find Beckman Coulter Life Sciences. For more details, visit beckman.com/contact-us
* Not intended or validated for use in diagnosis of disease or other conditions. The Biomek NGeniuS Next Generation Library Prep System is in development; performance characteristics have not been validated.
Beckman Coulter, the stylized logo, and the Beckman Coulter product and service marks mentioned herein, including Biomek and Biomek NGeniuS, are trademarks or registered trademarks of Beckman Coulter, Inc. in the United States and other countries. All other trademarks are the property of their respective owners.